Description |
The USP <2022> test is performed to determine the presence or absence of a specified list of microorganisms within nutritional and dietary supplements: Clostridium species, Escherichia coli, Salmonella species, and/or Staphylococcus aureus. As compared to USP <2021>, the sample is first enriched and then streaked onto the appropriate selective agar based upon the organism (s) above.
EMSL Test Code: P031 Validation/Suitability Test for USP <2021> and <2022> Package, Per Formulation
EMSL Test Code: P033 Validation/Suitability for USP <2022>, Per Formulation
EMSL Test Code: P004 Staphylococcus aureus via USP <62>/FDA BAM/USP <2022>
EMSL Test Code: P006 Escherichia coli via USP <62>/FDA BAM/USP <2022>
EMSL Test Code: P007 Salmonella spp. via USP <62>/FDA BAM/USP <2022>
EMSL Test Code: P012 Clostridium spp. via USP <62>/FDA BAM/USP <2022>
EMSL Test Code: P030 Pathogen Screening for Nutritional and Dietary Supplements via USP <2022> |